• Mark 1 Kit contains:
  • Atropine autoinjector
    • 2 mg in 0.7cc
  • Pralidoxime autoinjector (2-PAM)
    • 600 mg in 2cc
• Injection site selection:
  It is important that the injectors be given in a large muscle area.
  • The most common injection site of administration is the OUTER THIGH MUSCLE
  • For thinly built individuals, the injection should be given in the UPPER OUTER QUADRANT OF THE BUTTOCKS

Antidote administration:
Administer up to 3 Mark 1 Kits as needed

• Remove MARK 1 Kit from its protective pouch
• Grasp the atropine autoinjector (the smaller of the two) and remove it from slot number 1 of the plastic clip. The yellow safety cap will remain on the clip and the atropine autoinjector will now be armed, and the needle will eject from green tip

• Grasp the unit and position the green tip into the victim’s injection site (outer thigh or buttocks)
• Apply firm, even pressure until the autoinjector pushes the needle into the injection site and it begins firing. Using jabbing motion may result in improper injection or injury to the muscle

• Hold the injector firmly in place for at least 10 seconds.
• Carefully remove autoinjector from injection site (use caution as needle will be exposed)
• Remove the 2-PAM injector from slot number 2 of the clip